Protagonist Therapeutics, Inc.
PTGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $275,188 | -$78,955 | -$127,393 | -$125,551 |
| Dep. & Amort. | $2,895 | $3,312 | $3,369 | $2,775 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $37,554 | $29,293 | $24,202 | $16,395 |
| Change in WC | -$122,610 | -$19,511 | -$7,766 | -$3,314 |
| Other Non-Cash | -$8,875 | -$4,375 | -$549 | $1,830 |
| Operating Cash Flow | $184,152 | -$70,236 | -$108,137 | -$107,865 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,355 | -$609 | -$795 | -$1,101 |
| Net Acquisitions | $0 | $0 | -$91,468 | $14,759 |
| Inv. Purchases | -$621,702 | -$191,045 | -$214,874 | -$286,589 |
| Inv. Sales/Matur. | $323,574 | $152,396 | $307,137 | $271,830 |
| Other Inv. Act. | $0 | $0 | $91,468 | -$14,759 |
| Investing Cash Flow | -$299,483 | -$39,258 | $91,468 | -$15,860 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $26,453 | $132,100 | $14,553 | $123,829 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$600 | $38,377 | $4,285 | $6,094 |
| Financing Cash Flow | $25,853 | $170,477 | $18,838 | $129,923 |
| Forex Effect | $0 | $0 | -$90 | -$126 |
| Net Chg. in Cash | -$89,478 | $60,983 | $2,079 | $6,072 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $186,952 | $125,969 | $123,890 | $117,818 |
| End Cash | $97,474 | $186,952 | $125,969 | $123,890 |
| Free Cash Flow | $182,797 | -$70,845 | -$108,932 | -$108,966 |